CA3224467A1 - Modulateurs d'il-17a a base de phenyle acetamide et utilisations associees - Google Patents

Modulateurs d'il-17a a base de phenyle acetamide et utilisations associees

Info

Publication number
CA3224467A1
CA3224467A1 CA3224467A CA3224467A CA3224467A1 CA 3224467 A1 CA3224467 A1 CA 3224467A1 CA 3224467 A CA3224467 A CA 3224467A CA 3224467 A CA3224467 A CA 3224467A CA 3224467 A1 CA3224467 A1 CA 3224467A1
Authority
CA
Canada
Prior art keywords
optionally substituted
independently selected
halogen
substituents independently
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3224467A
Other languages
English (en)
Inventor
Maureen REILLY
Paul R. Fatheree
Claudio Aquino
Michael FREIDBERG
Timothy J. Church
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dice Alpha Inc
Original Assignee
Dice Alpha Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dice Alpha Inc filed Critical Dice Alpha Inc
Publication of CA3224467A1 publication Critical patent/CA3224467A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

La présente divulgation concerne des composés à base de phényle acétamide de formule (I), (I-a), (II), ainsi que des compositions pharmaceutiques correspondantes pour la modulation d'IL-17A, utiles dans le traitement d'états inflammatoires tels que le psoriasis.
CA3224467A 2021-07-09 2022-07-08 Modulateurs d'il-17a a base de phenyle acetamide et utilisations associees Pending CA3224467A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163220404P 2021-07-09 2021-07-09
US63/220,404 2021-07-09
US202163257896P 2021-10-20 2021-10-20
US63/257,896 2021-10-20
PCT/US2022/036569 WO2023283453A1 (fr) 2021-07-09 2022-07-08 Modulateurs d'il-17a à base de phényle acétamide et utilisations associées

Publications (1)

Publication Number Publication Date
CA3224467A1 true CA3224467A1 (fr) 2023-01-12

Family

ID=82851527

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3224467A Pending CA3224467A1 (fr) 2021-07-09 2022-07-08 Modulateurs d'il-17a a base de phenyle acetamide et utilisations associees

Country Status (5)

Country Link
EP (1) EP4366829A1 (fr)
KR (1) KR20240045220A (fr)
AU (1) AU2022307078A1 (fr)
CA (1) CA3224467A1 (fr)
WO (1) WO2023283453A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
BR9507200A (pt) 1994-03-25 1997-09-16 Isotechnika Inc Melhora da eficácia de drogas por deuteração
GB201709456D0 (en) * 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
WO2019223718A1 (fr) 2018-05-22 2019-11-28 成都先导药物开发股份有限公司 Immunomodulateur
GB201820166D0 (en) * 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
WO2020127685A1 (fr) 2018-12-19 2020-06-25 Leo Pharma A/S Anilides d'acides aminés en tant que modulateurs à petites molécules d'il-17
EP3935051A1 (fr) * 2019-03-08 2022-01-12 Leo Pharma A/S Modulateurs d'il-17 à petites molécules
JP2022547617A (ja) * 2019-09-16 2022-11-14 ダイス アルファ，インク． Ｉｌ－１７ａモジュレーターおよびその使用
WO2021098844A1 (fr) * 2019-11-20 2021-05-27 成都先导药物开发股份有限公司 Immunomodulateur
WO2022007461A1 (fr) * 2020-07-04 2022-01-13 成都先导药物开发股份有限公司 Immunomodulateur

Also Published As

Publication number Publication date
EP4366829A1 (fr) 2024-05-15
KR20240045220A (ko) 2024-04-05
WO2023283453A1 (fr) 2023-01-12
AU2022307078A1 (en) 2024-01-18

Similar Documents

Publication Publication Date Title
EP3952902A1 (fr) Formes posologiques et schémas de traitement pour des composés d'acides aminés
US6635630B2 (en) Selective neurokinin antagonists
JP6453231B2 (ja) ウレア誘導体、またはその薬理学的に許容される塩
IL305296A (en) Amino acid compounds and methods of use
AU2013341200A1 (en) Heteroaryl substituted pyridyl compounds useful as kinase modulators
JP2016532715A (ja) ＲＯＲγ調節因子
JP2001131171A (ja) 薬学的組成物
EP1237874A2 (fr) Antagonistes selectifs de la neurokine
JP2022520236A (ja) 化合物、組成物、及び、方法
AU2013243353B2 (en) Fused cyclopentyl antagonists of CCR2
WO2009024819A1 (fr) Ligands des récepteurs cannabinoïdes
JP7367004B2 (ja) 自己免疫疾患の処置のための新規のピラゾロビリジン化合物
WO2018015818A2 (fr) Composés inhibiteurs thérapeutiques
AU2003220215B9 (en) NK1 antagonists
IL303407A (en) New compounds as androgen receptor and dual phosphodiesterase inhibitor
JP2009520000A (ja) カンナビノイドｃｂ１受容体モジュレーターとしての４，５−ジヒドロ−（１ｈ）−ピラゾール誘導体
AU2021273001A1 (en) ENPP1 modulators and uses thereof
CA3224467A1 (fr) Modulateurs d'il-17a a base de phenyle acetamide et utilisations associees
WO2022217118A1 (fr) Modulateurs de ras à base de pyrimidine et leurs utilisations
AU2022265730A1 (en) Expanded dosage regimens for integrin inhibitors
CN117957212A (zh) 基于苯基乙酰胺的il-17a调节剂及其用途
WO2023225664A1 (fr) Modulateurs d'il-17a tels que l'imidazopyridazine à substitution lactame et leurs utilisations
WO2024026430A1 (fr) Composés de pyrimidine substitués en tant qu'inhibiteurs de tyk2
JP2013526529A (ja) 置換されたｎ−ヘテロアリールビピロリジンカルボキサミド、その製造及び治療上の使用